In a patent dispute between the original company and the generic company over generic for exclusivity, a study found that the generic company's first trial winning rate reached 88.5%.

Lee Myung-hee, a senior researcher at the KIIP, announced the results of the impact assessment of the licensing patent-linked system at the 2022 Pharmaceutical Intellectual Property Policy Forum co-hosted by the Ministry of Food and Drug Safety and the Korea Intellectual Property Protection Agency on the 15th. According to the researcher, a total of 1,087 patent trials have been filed over the nine years since 2013 until the end of last year. Generic companies have a winning rate of 88.5%. Generic companies claim the paten